amphetamine and sibutramine

amphetamine has been researched along with sibutramine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Balcioglu, A; Wurtman, RJ1
Golozoubova, V; Malmlöf, K; Strauss, F1
Caricati-Neto, A; da Silva Júnior, ED; de Souza, BP; Drawanz Pereira, J; Ferreira Verde, L; Jurkiewicz, A; Jurkiewicz, NH; Mendes Sobrinho, C; Miranda-Ferreira, R; Soubhi Smaili, S1

Reviews

1 review(s) available for amphetamine and sibutramine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for amphetamine and sibutramine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Sibutramine, a serotonin uptake inhibitor, increases dopamine concentrations in rat striatal and hypothalamic extracellular fluid.
    Neuropharmacology, 2000, Volume: 39, Issue:12

    Topics: Amphetamine; Animals; Chromatography, High Pressure Liquid; Cyclobutanes; Dopamine; Dopamine Uptake Inhibitors; Electrochemistry; Extracellular Space; Hypothalamus; Male; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Synaptosomes

2000
Locomotion is the major determinant of sibutramine-induced increase in energy expenditure.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 83, Issue:4

    Topics: 2,4-Dinitrophenol; Amphetamine; Animals; Appetite Depressants; Body Temperature; Cyclobutanes; Eating; Energy Metabolism; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Serotonin

2006
Changes of cytosolic calcium and contractility of young rat vas deferens by acute treatment with amphetamine, fluoxetine or sibutramine.
    European journal of pharmacology, 2012, Sep-15, Volume: 691, Issue:1-3

    Topics: Amphetamine; Animals; Calcium; Central Nervous System Agents; Cyclobutanes; Cytosol; Fluoxetine; Homeostasis; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Rats, Wistar; Time Factors; Vas Deferens

2012